Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria.
BACKGROUND: Currently, population pharmacokinetic (PK) studies of anti-malarial drugs are designed primarily by the logistical and ethical constraints of taking blood samples from patients, and the statistical models that are fitted to the data are not formally considered. This could lead to impreci...
Principais autores: | Jamsen, K, Duffull, S, Tarning, J, Lindegardh, N, White, N, Simpson, J |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
BioMed Central
2011
|
Registros relacionados
-
Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria
por: Lindegardh Niklas, et al.
Publicado em: (2011-07-01) -
Optimal designs for population pharmacokinetic studies of the partner drugs co-administered with artemisinin derivatives in patients with uncomplicated falciparum malaria.
por: Jamsen, K, et al.
Publicado em: (2012) -
Optimal designs for population pharmacokinetic studies of the partner drugs co-administered with artemisinin derivatives in patients with uncomplicated falciparum malaria
por: Jamsen Kris M, et al.
Publicado em: (2012-07-01) -
Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria.
por: Tarning, J, et al.
Publicado em: (2012) -
Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria
por: Tarning, J, et al.
Publicado em: (2012)